交易中 05-20 11:43:32 美东时间
-0.265
-2.63%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
RBC Capital analyst Matthew Swanson maintains PubMatic (NASDAQ:PUBM) with a Outperform and raises the price target from $11 to $13.
05-09 01:45
PubMatic (NASDAQ:PUBM) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.32) by 65.63 percent. This is a 175 percent decrease over losses of $(0.04) per share from the same
05-08 04:28
PayPal Holdings (PYPL) introduced PayPal Ads ID, an identifier based on verified commerce relationships, to enable more precise targeting of ads, the company said Monday. By contrast, most identity so...
04-28 00:28
PubMatic (PUBM) on Wednesday reported preliminary unaudited first quarter 2026 revenue to be approximately $62.4M vs. consensus of $58.95M, with approximately $2.5 million in adjusted EBITDA. The com...
04-23 05:15
The Company expects first quarter 2026 revenue to be approximately $62.4 million, with approximately $2.5 million in adjusted EBITDA. These figures exceed PubMatic's previously-issued first quarter 2026 guidance of $58.0
04-23 05:08
PubMatic partners with Untapped Growth to integrate independent agencies into AgenticOS; early campaigns cut supply chain costs 40-50% PubMatic partnered with Untapped Growth to give independent agencies direct integration into AgenticOS, enabling deployment of proprietary buyer agents. Early Agenti
03-25 21:03
Optable, the Agentic Audience Platform, today announced a partnership with PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, to bring privacy-safe,
03-12 21:04
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
B. Riley Securities analyst Zach Cummins upgrades PubMatic (NASDAQ:PUBM) from Neutral to Buy and raises the price target from $10 to $10.5.
02-27 18:46